In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Advertisement
Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

Qiagen In Crisis, Previews Poor Q3 Sales; Long-Term CEO Steps Down

Qiagen shares took a hit following a series of negative announcements, including lower than expected results for Q3 2019 and the departure of long-term CEO Peer Schatz. The company said it had been affected by poor sales growth in China.

Sales & Earnings In Vitro Diagnostics

Accelmed Launches New $100M Venture Medtech Fund

Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.

 

Digital Health Commercial

Exec Chat: Intuitive Surgical CEO Gary Guthart On Expansion, Innovation And Competition

With the opening of a new UK & Ireland headquarters last month, Intuitive Surgical is aiming to strengthen its grip on the the market as it faces increasing competition in the robotic surgery space. CEO Gary Guthart sat down with Medtech Insight at its new Oxfordshire, UK HQ to discuss expansion and innovation plans.

Exec Chat Business Strategies

Device Week, 4 October 2019 – Demant Group Recovers From Cyber-Attack; TCT Conference Highlights

In this week's podcast, senior reporter Catherine Longworth provides an update on how the Demant Group is recovering from a ransomware attack that forced the Danish hearing-aid manufacturer to shut down its IT systems, and deputy editor Reed Miller reviews the highlights of the clinical trial presentations at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.

Device Week Commercial

Medtech Achievers Sparkle At The 2019 Medtech Insight Awards

The winners of this year’s Medtech Insight Awards were revealed last night at a glittery ceremony in Boston. The awards, held in partnership with the MedTech Conference, recognized excellence and achievement across the industry.

Innovation Companies

Device Week, 20 September 2019 – Medtech Giants Sign Major Diabetes Partnerships

In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Marion Webb about two new major partnerships signed in the diabetes sector, and finds out more about ResMed’s growth strategy.

Device Week Diabetic Care
See All
Advertisement
UsernamePublicRestriction

Register